Abstract
Isolated dystonia is a disorder characterized by involuntary twisting postures arising from sustained muscle contractions. Although autosomal-dominant mutations in TOR1A, THAP1, and GNAL have been found in some cases, the molecular mechanisms underlying isolated dystonia are largely unknown. In addition, although emphasis has been placed on dominant isolated dystonia, the disorder is also transmitted as a recessive trait, for which no mutations have been defined. Using whole-exome sequencing in a recessive isolated dystonia-affected kindred, we identified disease-segregating compound heterozygous mutations in COL6A3, a collagen VI gene associated previously with muscular dystrophy. Genetic screening of a further 367 isolated dystonia subjects revealed two additional recessive pedigrees harboring compound heterozygous mutations in COL6A3. Strikingly, all affected individuals had at least one pathogenic allele in exon 41, including an exon-skipping mutation that induced an in-frame deletion. We tested the hypothesis that disruption of this exon is pathognomonic for isolated dystonia by inducing a series of in-frame deletions in zebrafish embryos. Consistent with our human genetics data, suppression of the exon 41 ortholog caused deficits in axonal outgrowth, whereas suppression of other exons phenocopied collagen deposition mutants. All recessive mutation carriers demonstrated early-onset segmental isolated dystonia without muscular disease. Finally, we show that Col6a3 is expressed in neurons, with relevant mRNA levels detectable throughout the adult mouse brain. Taken together, our data indicate that loss-of-function mutations affecting a specific region of COL6A3 cause recessive isolated dystonia with underlying neurodevelopmental deficits and highlight the brain extracellular matrix as a contributor to dystonia pathogenesis.
Original language | English (US) |
---|---|
Pages (from-to) | 883-893 |
Number of pages | 11 |
Journal | American journal of human genetics |
Volume | 96 |
Issue number | 6 |
DOIs | |
State | Published - May 1 2015 |
Funding
We thank all individuals with dystonia and their family members who participated in this study. We are gratefully indebted to Jelena Golic, Susanne Lindhof, Sybille Frischholz, and Regina Feldmann (Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany) and Melanie Plastini (Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, USA) for expert technical assistance, and our study nurses Silke Zwirner and Antje Lüsebrink (Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany). We thank Dr. Kornelia Kreiser, Abteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universität München (Munich, Germany) for the performance of muscle MRI. We thank Erik Tilch for help with CADD. This study was funded by in-house institutional funding from Technische Universität München and Helmholtz Zentrum München, Munich, Germany, by seed funding from the Center for Human Disease Modeling, Duke University, and by P50 MH094268 to N.K. Recruitment of case and control cohorts was supported by institutional funding from Helmholtz Zentrum München, Munich, Germany, and government funding from the German Bundesministerium für Bildung und Forschung (BMBF, 03.2007-02.2011 FKZ 01ET0713). Fibroblasts were obtained from the Medical Research Council (MRC) Centre for Neuromuscular Diseases Biobank (Newcastle), which is part of EuroBioBank. The EU funded projects Neuromics (No. 305121) and RD-Connect (No. 305444). N.K. is a Distinguished Brumley Professor. M.Z. received intramural funding from the Langmatz-Stiftung.
ASJC Scopus subject areas
- Genetics(clinical)
- Genetics